Healthcare
from24/7 Wall St.
3 days agoWhy One Analyst Thinks Johnson & Johnson Reaches $280
Johnson & Johnson stock has surged 48% over the past year, with HSBC raising its price target to $280, driven by oncology growth, defensive sector rotation, and upcoming business separation.